Stock Market and Business News on Jul 02 2024 - CSIMarket.com
CSIMarket

Management Announcement

CytoSorbents Secures $20 Million Credit Facility to Support Regulatory and Commercialization Goals

July 2, 2024



In a significant development for medical device company CytoSorbents, the company recently announced securing a $20 million credit facility, providing them with a valuable injection of non-dilutive capital to accelerate their regulatory and commercialization objectives. This crucial funding comes at a time...

Management Announcement

Beneficient Announces Termination of SEC Investigation and Achieves Highest Return on Assets in Financial Sector

July 2, 2024


In a recent announcement, Beneficient (BENF) revealed that the U.S. Securities and Exchange Commission (SEC) has concluded its investigation into the company and its CEO, Brad Heppner. The termination letters issued signify the end of the inquiry, bringing relief to the company and its stakeholders.
During ...

Stocks on the Move

Naas Technology Inc Rises from Compliance Concerns, Poised to Capitalize on EV Charging Market Growth

July 2, 2024

Naas Technology Inc Shares Regain Compliance with Nasdaq s Minimum Bid Price Requirement, Providing Relief to Frustrated InvestorsNaas Technology Inc (NASDAQ: NAAS) has been a source of frustration for investors this year, with the stock experiencing a series of ups and downs. However, recent events have provided so...

Contract

Gilat Satellite Networks Secures $9M Contract with US Department of Defense while Facing Revenue Challenges

July 2, 2024

Gilat Satellite Networks Ltd, a global provider of satellite networking technology and services, has recently been awarded a lucrative contract worth over $9 million by the US Department of Defense (DoD). This contract is vital in supporting critical connectivity requirements for the DoD s Technical and Field Servic...

Licensing Agreement

Checkpoint Therapeutics Biologics License Application Resubmission for Cosibelimab Brings New Hope for Advanced cSCC...

July 2, 2024

Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, has recently announced that it has completed the resubmission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for cosibelimab. Cosibelimab is an anti-programmed death ligand-1 (PD-L1) anti...

Our most Popular Articles
Merger and Acquisition

Core & Main Bolsters St. Louis Presence with Completion of Eastern Supply Acquisition

February 13, 2024

Core & Main Completes Acquisition of Eastern Supply, Expanding Market Presence in St. Louis
St. Louis-based Core & Main Inc. (NYSE: CNM) has finalized its acquisition of Eastern Supply Inc., a move that significantly enhances the company s presence in the bustling St. Louis market. The acquisition, which was ann...

Contract

Prudential and RGA Secure $5.9 Billion Pension Deal with Verizon, While Prudential Financial Inc. Sees Mixed Results with Corporate Clients

March 6, 2024

In a significant move within the pension industry, Prudential Financial Inc. (NYSE: PRU) and Reinsurance Group of America, Incorporated (NYSE: RGA) have been entrusted with fulfilling $5.9 billion in pension promises for Verizon Communications Inc. This landmark transaction aims to provide retirement security for a ...

Product Service News

Amneal's Exclusive Licensing Agreement with Zambon Brings Promising Parkinson's Disease Treatment to Europe

February 27, 2024

Amneal Pharmaceuticals, Inc. has recently entered into an exclusive licensing agreement with Zambon Biotech SA to bring a novel treatment for Parkinson s disease (PD) to the European Union, United Kingdom, and Switzerland. The licensing agreement covers the distribution and commercialization of IPX203, an oral formu...

Company News
Management Announcement

Beneficient Announces Termination of SEC Investigation and Achieves Highest Return on Assets in Financial Sector

July 2, 2024


In a recent announcement, Beneficient (BENF) revealed that the U.S. Securities and Exchange Commission (SEC) has concluded its investigation into the company and its CEO, Brad Heppner. The termination letters issued signify the end of the inquiry, bringing relief to the company and its stakeholders.
During ...

Stocks on the Move

Naas Technology Inc Rises from Compliance Concerns, Poised to Capitalize on EV Charging Market Growth

July 2, 2024

Naas Technology Inc Shares Regain Compliance with Nasdaq s Minimum Bid Price Requirement, Providing Relief to Frustrated InvestorsNaas Technology Inc (NASDAQ: NAAS) has been a source of frustration for investors this year, with the stock experiencing a series of ups and downs. However, recent events have provided so...

Stocks on the Move

Uncovering the True Value of Sagimet Biosciences Inc (SGMT) Stock Assessing Recent Developments and Their Impact on Market Performance

July 2, 2024

Sagimet Biosciences Inc (SGMT) is a pharmaceutical company that has been recently influenced by multiple news articles and developments. This article aims to interpret and analyze these articles to assess their impact on the performance of Sagimet Biosciences Inc shares and shed light on the hidden value beneath the...

Company News
Stocks on the Move

Vicarious Surgical Incs Struggle to Keep Pace with the Market A Closer Look at the Numbers

July 2, 2024
Company News
Stocks on the Move

The Growth Story Behind 5E Advanced Materials Incs Market Performance Discrepancy

July 2, 2024
Company News
Stocks on the Move

Autodesk Inc. Advancing the Future of Design and Technology

July 2, 2024
More Company News
Financing Agreement

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

July 2, 2024
Product Service News

Revolutionary Gene Therapy Shows Promise in Treating Myasthenia Gravis

July 2, 2024
Management Announcement

Immuron Files Pre-IND Application with FDA for IMM-529, Stocks Surge 17.82% in Five Trading Days.

July 2, 2024
Management Announcement

Massachusetts Police Chiefs Unite to Vouch for ShotSpotter's Accuracy, Effectiveness, and Value Amidst Controversy

July 2, 2024
Financing Agreement

Freedom Holdings Charts a New Path Forward with the Signing of a Milestone Letter of Intent

July 2, 2024
Stocks on the Move

Bath and Body Works Shares Decline as Company Faces Thefts and Revenue Challenges

July 2, 2024
Business Update

Vonage Maintains Leadership Position in Gartner Magic Quadrant for Communications Platform as a Service for Second Co...

July 2, 2024
Business Update

Marqeta Partners with Swiss4 to Redefine Personalized Payment Experiences in Switzerland

July 2, 2024
Licensing Agreement

InterDigital Expands Technological Footprint, Renews Vital Partnerships, and Forms Strategic Alliance with Google...

July 2, 2024
Stocks on the Move

Teradata Corporation Faces Multiple Legal Challenges as Investors Seek Redress

July 2, 2024
Related News
Stocks on the Move

Leggett and Platt Inc Faces Investor Frustration as Share Performance Lags Market

Stocks on the Move

OReilly Automotive Inc. Struggles to Keep Pace with Market, Raising Investor Concerns

Stocks
Stocks on the Move

Merck & Co Inc Battles Underperformance, Alleged Drug Trafficking, and Inventory Challenges A Roadmap to Recovery

Stocks on the Move

ADC Therapeutics Augmenting Treatment with Antibody Drug Conjugates

Stocks on the Move

Environmental and Facilities Services Companies Show Mixed Q1 Earnings Performance

Business News
Contract

Gilat Satellite Networks Secures $9M Contract with US Department of Defense while Facing Revenue Challenges

Gilat Satellite Networks Ltd, a global provider of satellite networking technology and services, has recently been awarded a lucrative contract worth over $9 million by the US Department of Defense (DoD). This contract is vital in supporting critical connectivity requirements for the DoD s Technical and Field Servic...

Licensing Agreement

Checkpoint Therapeutics Biologics License Application Resubmission for Cosibelimab Brings New Hope for Advanced cSCC...

Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, has recently announced that it has completed the resubmission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for cosibelimab. Cosibelimab is an anti-programmed death ligand-1 (PD-L1) anti...

Management Announcement

Sail in Style and Luxury: Chris-Craft*s Sportster 25 Sets a New Benchmark in Boating Excellence

Chris-Craft Introduces New Sportster 25: Setting a New Standard of Excellence in Boating
In the world of boating, Chris-Craft has long been associated with unparalleled craftsmanship, elegant design, and uncompromising quality. With their latest offering, the Sportster 25, Chris-Craft once again affirms their po...

Product Service News

ANI Pharmaceuticals Expands Generic Medication Portfolio with FDA Approval and Triple Product Launch in 2024...

ANI Pharmaceuticals Continues Strong Market Presence with FDA Approval and Launch of New Generic Medications Princeton, N.J., July 02, 2024 - ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a leading U.S. specialty pharmaceutical company, has announced the FDA approval of its Abbreviated New Drug Application (ANDA) for ...

Management Announcement

CytoSorbents Secures $20 Million Credit Facility to Support Regulatory and Commercialization Goals



In a significant development for medical device company CytoSorbents, the company recently announced securing a $20 million credit facility, providing them with a valuable injection of non-dilutive capital to accelerate their regulatory and commercialization objectives. This crucial funding comes at a time...

Our Most Popular Articles
Merger and Acquisition

Core & Main Bolsters St. Louis Presence with Completion of Eastern Supply Acquisition

Core & Main Completes Acquisition of Eastern Supply, Expanding Market Presence in St. Louis
St. Louis-based Core & Main Inc. (NYSE: CNM) has finalized its acquisition of Eastern Supply Inc., a move that significantly enhances the company s presence in the bustling St. Louis market. The acquisition, which was ann...

Contract

Prudential and RGA Secure $5.9 Billion Pension Deal with Verizon, While Prudential Financial Inc. Sees Mixed Results with Corporate Clients

In a significant move within the pension industry, Prudential Financial Inc. (NYSE: PRU) and Reinsurance Group of America, Incorporated (NYSE: RGA) have been entrusted with fulfilling $5.9 billion in pension promises for Verizon Communications Inc. This landmark transaction aims to provide retirement security for a ...

Product Service News

Amneal's Exclusive Licensing Agreement with Zambon Brings Promising Parkinson's Disease Treatment to Europe

Amneal Pharmaceuticals, Inc. has recently entered into an exclusive licensing agreement with Zambon Biotech SA to bring a novel treatment for Parkinson s disease (PD) to the European Union, United Kingdom, and Switzerland. The licensing agreement covers the distribution and commercialization of IPX203, an oral formu...

More News
Management Announcement

Beneficient Announces Termination of SEC Investigation and Achieves Highest Return on Assets in Financial Sector


In a recent announcement, Beneficient (BENF) revealed that the U.S. Securities and Exchange Commission (SEC) has concluded its investigation into the company and its CEO, Brad Heppner. The termination letters issued signify the end of the inquiry, bringing relief to the company and its stakeholders.
During ...

Stocks on the Move

Naas Technology Inc Rises from Compliance Concerns, Poised to Capitalize on EV Charging Market Growth

Naas Technology Inc Shares Regain Compliance with Nasdaq s Minimum Bid Price Requirement, Providing Relief to Frustrated InvestorsNaas Technology Inc (NASDAQ: NAAS) has been a source of frustration for investors this year, with the stock experiencing a series of ups and downs. However, recent events have provided so...

Stocks on the Move

Uncovering the True Value of Sagimet Biosciences Inc (SGMT) Stock Assessing Recent Developments and Their Impact on Market Performance

Sagimet Biosciences Inc (SGMT) is a pharmaceutical company that has been recently influenced by multiple news articles and developments. This article aims to interpret and analyze these articles to assess their impact on the performance of Sagimet Biosciences Inc shares and shed light on the hidden value beneath the...

Stocks on the Move

Vicarious Surgical Incs Struggle to Keep Pace with the Market A Closer Look at the Numbers

In the ever-evolving world of stock markets, performance can often be an enigma, leaving investors pondering why certain companies trail behind the overall market. Vicarious Surgical Inc, an advanced robotics technology company specializing in surgery, seems to be facing such a challenge. Despite being a key player ...

Stocks on the Move

The Growth Story Behind 5E Advanced Materials Incs Market Performance Discrepancy

In the world of advanced materials and industrial solutions, 5E Advanced Materials Inc (NASDAQ: FEAM) has emerged as a prominent player. However, despite its rising stock price and customer qualification programs, the company s shares have failed to match the overall market s performance. With the help of articles f...

Stocks on the Move

Autodesk Inc. Advancing the Future of Design and Technology

Autodesk Inc.: A Promising Stock with Strong Growth PotentialBy examining recent events and financial performance, it is evident that Autodesk Inc. (NASDAQ: ADSK) is a company with considerable promise. With a solid financial position, strategic acquisitions, and positive analyst sentiment, the stock is positioned f...

Financing Agreement

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing



In a recent announcement, Cartesian Therapeutics, a clinical-stage biotechnology company focusing on mRNA cell therapy for autoimmune diseases, revealed that it has entered into a securities purchase agreement for private investment in public equity (PIPE) financing. The company expects to generate approxi...

Product Service News

Revolutionary Gene Therapy Shows Promise in Treating Myasthenia Gravis

In a major breakthrough, Cartesian Therapeutics has recently announced positive topline results from their Phase 2b trial of Descartes-08, a promising gene therapy for patients suffering from Myasthenia Gravis (MG). The trial successfully met its primary endpoint, demonstrating statistically significant improvement ...

Management Announcement

Immuron Files Pre-IND Application with FDA for IMM-529, Stocks Surge 17.82% in Five Trading Days.

Immuron Requests Pre-IND Meeting with FDA for IMM-529 and Shares Soar 17.82% in Five Trading Days
Melbourne, Australia - Immuron Limited (ASX: IMC; NASDAQ: IMRN), a leading global biopharmaceutical company based in Australia, is excited to announce the submission of a pre-IND (investigational new drug) applicati...

Management Announcement

Massachusetts Police Chiefs Unite to Vouch for ShotSpotter's Accuracy, Effectiveness, and Value Amidst Controversy

Massachusetts Police Leaders Firmly Stand Behind ShotSpotter s Accuracy, Effectiveness, and Value Despite Recent Misleading Assertions
Stock of SoundThinking, Inc. Takes a Downturn Amidst Controversial Claims
In a bold move to dispel recent misleading assertions made by four members of Congress against the e...

Financing Agreement

Freedom Holdings Charts a New Path Forward with the Signing of a Milestone Letter of Intent


In a significant development, Freedom Holdings has recently announced that the management has signed a letter of intent, marking a crucial milestone for the company. This strategic move is set to shape the future trajectory of Freedom Holdings, as it ushers in new opportunities and paves the way for further gro...

Stocks on the Move

Bath and Body Works Shares Decline as Company Faces Thefts and Revenue Challenges

In recent months, Bath and Body Works Inc. has experienced a decline in share performance, trailing behind the overall market. This article aims to analyze the impact of recent events and trends on the company s stock value. Specifically, we will examine incidents such as thefts at their stores, sales promotions, le...

Business Update

Vonage Maintains Leadership Position in Gartner Magic Quadrant for Communications Platform as a Service for Second Co...

Vonage, the global leader in cloud communications and digital transformation solutions, has once again cemented its position as a leader in the Gartner Magic Quadrant for Communications Platform as a Service (CPaaS). This marks the second year in a row that Vonage has been recognized as a leader in both Ability to Execute and Completeness of Vision.Gartner, the renowned global research and advisory firm, thoroughly evaluated various CPaaS providers, analyzing their ability to deliver effective solutions and innovations to businesses seeking to accelerate their digital transformation. Vonage s strong performance and commitment to innovation have placed it in the esteemed Leaders Quadrant, further solidifying its position as a pioneer in the industry.

Business Update

Marqeta Partners with Swiss4 to Redefine Personalized Payment Experiences in Switzerland

Marqeta Empowers Swiss4 to Deliver Personalized Payment Experiences in SwitzerlandOAKLAND, Calif. - Marqeta (NASDAQ: MQ), the leading global card issuing platform for embedded finance solutions, has announced its partnership with Swiss4, a provider of real-time and personalized digital payment services. This partner...

Licensing Agreement

InterDigital Expands Technological Footprint, Renews Vital Partnerships, and Forms Strategic Alliance with Google...

InterDigital Reinforces its Technological Dominance with Renewed License Agreements and Google PartnershipWilmington, Del., Jan. 10, 2024 - InterDigital, Inc., a pioneering mobile and video technology research and development company, continues to solidify its position as a leader in the industry with two significan...

Stocks on the Move

Teradata Corporation Faces Multiple Legal Challenges as Investors Seek Redress

Teradata Corporation (NYSE: TDC), a leading provider of data analytics solutions, is currently grappling with a series of legal battles and a decline in share prices. Multiple law firms have initiated class action lawsuits against the company on behalf of investors who suffered losses. This article will delve into t...



Previous News 1. Page 388. Page 389. Page 390. Page .... 437. Page .... 487. Page NEXT 
Previous News


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.